What helps hair loss depends largely on the underlying cause, making accurate diagnosis the essential first step. Hair loss affects millions of people across the UK, ranging from hereditary androgenetic alopecia to temporary shedding triggered by stress or nutritional deficiencies. Effective options include licensed topical and oral medications, specialist treatments for autoimmune conditions, and supportive lifestyle changes. This article outlines the main causes, evidence-based treatments available in the UK, relevant NHS and NICE guidance, and when to seek medical advice — helping you understand which approaches are most appropriate for your situation.
Summary: What helps hair loss depends on the cause, but evidence-based options include topical minoxidil, prescription finasteride for men, corticosteroid injections or JAK inhibitors for alopecia areata, and addressing underlying nutritional or medical conditions.
- Androgenetic alopecia is the most common type, driven by DHT sensitivity and treated with minoxidil or finasteride (men only).
- Minoxidil is available over the counter in the UK; results take 3–6 months and treatment must be continued to maintain benefit.
- Finasteride 1 mg is prescription-only, not routinely available on the NHS, and carries MHRA warnings for depression and suicidal ideation.
- Baricitinib and ritlecitinib are MHRA-approved JAK inhibitors for severe alopecia areata, initiated by specialists and subject to NICE appraisal for NHS access.
- Nutritional deficiencies (iron, vitamin D, zinc) can contribute to shedding; supplements should only be taken where deficiency is confirmed.
- Suspected scarring alopecia or tinea capitis warrants urgent GP or dermatology assessment to prevent permanent hair loss.
Table of Contents
Am I eligible for weight loss injections?
Find out whether you might be eligible!
Answer a few quick questions to see whether you may be suitable for prescription weight loss injections (like Wegovy® or Mounjaro®).
- No commitment — just a quick suitability check
- Takes about 1 minute to complete
Common Causes of Hair Loss in the UK
Androgenetic alopecia is the most common cause, driven by DHT sensitivity, but hair loss can also result from autoimmune conditions, thyroid disorders, iron deficiency, scalp infections, medications, or hormonal changes.
Not sure if this is normal? Chat with one of our pharmacists →
Hair loss is a common concern affecting millions of people across the UK, with causes ranging from genetic factors to underlying medical conditions. Understanding the root cause is essential before exploring what helps hair loss, as treatment effectiveness depends heavily on the type of hair loss involved.
The most prevalent form is androgenetic alopecia (male- or female-pattern baldness), which is hereditary and affects both sexes, though it presents differently. In men, it typically causes a receding hairline and crown thinning, whilst women more commonly experience diffuse thinning across the top of the scalp. This condition is driven by sensitivity to dihydrotestosterone (DHT), a derivative of testosterone.
Other common causes include:
-
Alopecia areata – an autoimmune condition causing patchy hair loss
-
Telogen effluvium – temporary shedding triggered by stress, illness, surgery, nutritional deficiencies, or the postpartum period; hair typically regrows once the trigger resolves
-
Thyroid disorders – both hypothyroidism and hyperthyroidism can disrupt the hair growth cycle
-
Iron deficiency anaemia – particularly common in women of reproductive age
-
Scalp conditions such as seborrhoeic dermatitis (which may increase shedding and fragility rather than cause true alopecia) or tinea capitis (scalp ringworm), which requires prompt assessment and systemic antifungal treatment — especially in children
-
Scarring alopecias (e.g., lichen planopilaris, frontal fibrosing alopecia) — less common but important to identify early, as hair loss can be permanent if untreated
-
Trichotillomania – compulsive hair pulling, which may benefit from psychological support
Certain medications can also contribute to hair loss, including anticoagulants, antidepressants, antiepileptics, beta-blockers, retinoids (including isotretinoin), and chemotherapy agents; this list is not exhaustive, and a pharmacist or GP can advise on specific medicines. Hormonal changes associated with pregnancy, the menopause, or stopping the combined oral contraceptive pill may also trigger temporary shedding.
Identifying the underlying cause — ideally with a GP or dermatologist — is the critical first step in determining the most appropriate and effective course of action.
| Treatment | Type | Suitable For | Availability (UK) | Typical Timescale | Key Considerations |
|---|---|---|---|---|---|
| Minoxidil 2% / 5% | Topical solution or foam | Androgenetic alopecia (men and women) | Over the counter (OTC) | 3–6 months for visible results | Must be used continuously; avoid in pregnancy; may cause scalp irritation or unwanted facial hair |
| Finasteride 1 mg | Oral tablet (5-alpha reductase inhibitor) | Male-pattern baldness only | Private prescription only; not routinely on NHS | 3–6 months; ongoing use required | MHRA warning: depression and suicidal ideation; not for women of childbearing age; report via Yellow Card |
| Corticosteroid injections | Intralesional injection | Alopecia areata (patchy) | NHS or private via dermatologist | Weeks to months | Administered in specialist settings; repeated sessions may be needed |
| Baricitinib (Olumiant) | Oral JAK inhibitor | Severe alopecia areata in adults | NHS subject to NICE technology appraisal; specialist initiation | Consult SmPC | Risks include serious infections, VTE, cardiovascular events, malignancy; contraindicated in pregnancy |
| Ritlecitinib (Litfulo) | Oral JAK inhibitor | Severe alopecia areata; adults and adolescents ≥12 years | NHS subject to NICE technology appraisal; specialist initiation | Consult SmPC | Similar safety profile to baricitinib; review vaccination status before starting; report via Yellow Card |
| Nutritional optimisation | Lifestyle / dietary | Telogen effluvium; deficiency-related shedding | Self-managed; GP-guided testing advised | Variable; months after deficiency corrected | Address confirmed deficiencies (iron, ferritin, vitamin D, zinc); excess selenium or vitamin A can worsen loss |
| Hair transplant surgery | Surgical procedure | Androgenetic alopecia (suitable candidates) | Rarely NHS; mainly private; verify CQC/GMC registration | Final results up to 12–18 months post-procedure | Costly; requires realistic expectations; thorough pre-procedure risk discussion essential |
Treatments That Can Help With Hair Loss
Topical minoxidil (OTC) and oral finasteride (prescription-only, men) are the main evidence-based options for pattern hair loss; JAK inhibitors baricitinib and ritlecitinib are licensed for severe alopecia areata in specialist settings.
Several evidence-based treatments are available in the UK, and the most suitable option will depend on the type and severity of hair loss. It is important to have realistic expectations, as most treatments slow progression or promote partial regrowth rather than offering a complete cure.
Minoxidil is one of the most widely used topical treatments and is available over the counter in the UK as a 2% or 5% solution or foam, applied directly to the scalp. Originally developed as an antihypertensive, it was found to stimulate hair follicles and prolong the anagen (growth) phase of the hair cycle. Key points to be aware of:
-
Results typically take three to six months to become visible, and treatment must be continued to maintain any benefit; stopping treatment leads to loss of any regrowth
-
An initial increase in shedding during the first few weeks is common and usually temporary
-
It should be avoided during pregnancy and breastfeeding
-
Common side effects include scalp irritation or contact dermatitis; unwanted facial hair growth can occur in women
-
Rare systemic effects (e.g., low blood pressure) have been reported; refer to the product's Summary of Product Characteristics (SmPC) for full prescribing information
Finasteride 1 mg is a prescription-only oral medication for male-pattern baldness. It works by inhibiting the enzyme 5-alpha reductase, thereby reducing DHT levels and slowing follicle miniaturisation. Important considerations:
-
It is not routinely available on the NHS in the UK for hair loss and is generally supplied via private prescription
-
It is not licensed for use in women, particularly those of childbearing age, due to risks of foetal harm; women who are pregnant or may become pregnant should not handle crushed or broken tablets
-
The MHRA has issued safety warnings regarding risks of depression and suicidal ideation — patients should stop taking finasteride and seek medical advice immediately if they experience mood changes
-
Other potential side effects include reduced libido, erectile dysfunction, and effects on fertility; in some men, sexual dysfunction has persisted after stopping the medicine
-
Patients should report any suspected side effects via the MHRA Yellow Card Scheme (yellowcard.mhra.gov.uk or the Yellow Card app)
For alopecia areata, treatments may include:
-
Corticosteroid injections into affected areas
-
Topical immunotherapy (e.g., diphencyprone), administered in specialist settings
-
Baricitinib — a JAK inhibitor approved by the MHRA for severe alopecia areata in adults; access via the NHS is subject to NICE technology appraisal guidance
-
Ritlecitinib — a JAK inhibitor licensed in the UK for severe alopecia areata in adults and adolescents aged 12 years and over; NHS access is similarly subject to NICE technology appraisal criteria
Both baricitinib and ritlecitinib are initiated and monitored by specialists. They carry important safety considerations, including increased risk of serious infections, venous thromboembolism, major adverse cardiovascular events, and malignancy. They are contraindicated in pregnancy, and vaccination status should be reviewed before starting treatment. Patients should report any suspected side effects via the MHRA Yellow Card Scheme.
Experiencing these side effects? Our pharmacists can help you navigate them →
Interventions such as platelet-rich plasma (PRP) therapy and low-level laser devices are available privately in the UK, but evidence for their effectiveness is limited and variable; they are not routinely recommended by NICE.
Hair transplant surgery is another option for suitable candidates, though it is rarely available on the NHS and can be costly privately. Patients should seek practitioners registered with the Care Quality Commission (CQC) and verify that the operating surgeon is registered with the General Medical Council (GMC). Realistic expectations and a thorough discussion of risks should form part of any pre-procedure consultation.
NHS and NICE Guidance on Hair Loss Management
NICE does not routinely fund treatment for androgenetic alopecia on the NHS as it is considered cosmetic; referral to dermatology is recommended for scarring alopecia, extensive alopecia areata, or diagnostic uncertainty.
The NHS and NICE provide a framework for the assessment and management of hair loss, emphasising the importance of accurate diagnosis before initiating treatment. NICE Clinical Knowledge Summaries (CKS) offer guidance for primary care clinicians on the investigation and referral of patients presenting with hair loss.
For androgenetic alopecia, NICE notes that treatment is not routinely available on the NHS, as the condition is generally considered cosmetic. GPs can advise on licensed over-the-counter options such as topical minoxidil. Finasteride 1 mg for male-pattern hair loss is not routinely available on the NHS and is generally obtained via private prescription. Women with female-pattern hair loss may be referred to a dermatologist if the diagnosis is uncertain or if first-line measures are ineffective.
For alopecia areata, NICE recommends a watchful waiting approach in mild cases, as spontaneous regrowth occurs in many patients within a year. Referral to secondary care is advised for:
-
Extensive or rapidly progressing hair loss
-
Significant psychological distress
-
Cases where the diagnosis is unclear
-
Suspected scarring alopecia — urgent dermatology referral is recommended to prevent permanent hair loss
-
Suspected tinea capitis, particularly in children — prompt assessment and systemic antifungal treatment are required
Investigations should be targeted based on clinical history and examination findings rather than offered routinely to all patients. Where clinically indicated, tests may include:
-
Full blood count (to detect anaemia)
-
Thyroid function tests
-
Serum ferritin (iron stores)
-
Hormone profile (particularly in women with signs of androgen excess or hyperandrogenism)
The MHRA has approved baricitinib (Olumiant) and ritlecitinib (Litfulo) for severe alopecia areata. NHS access to both medicines is subject to NICE technology appraisal guidance and is provided through specialist services. Patients experiencing hair loss with significant psychological impact should be supported with appropriate mental health resources — such as NHS talking therapies — as the NHS recognises the considerable emotional burden this condition can carry.
Lifestyle Changes That May Support Hair Growth
A balanced diet ensuring adequate iron, protein, zinc, and vitamin D supports follicle health, but lifestyle changes alone are unlikely to reverse significant hair loss and should complement medical treatment.
Whilst lifestyle changes alone are unlikely to reverse significant hair loss, they can play a meaningful supportive role — particularly where nutritional deficiencies or lifestyle factors are contributing to shedding. Addressing these factors may help create an optimal environment for hair follicle health.
Nutrition is one of the most important considerations. A balanced diet rich in the following nutrients is associated with healthy hair growth:
-
Iron and ferritin — found in red meat, lentils, spinach, and fortified cereals
-
Biotin (Vitamin B7) — present in eggs, nuts, and wholegrains; true deficiency is rare in people eating a varied diet
-
Zinc — found in shellfish, seeds, and legumes
-
Vitamin D — low levels have been associated with alopecia areata, though evidence remains preliminary
-
Protein — hair is primarily composed of keratin, making adequate protein intake essential
Supplements should only be taken where a deficiency has been confirmed through blood testing. Excessive supplementation of certain nutrients — such as selenium or vitamin A — can paradoxically worsen hair loss. If you are taking biotin supplements, inform your clinician before blood tests, as high-dose biotin can interfere with a range of laboratory assays (including thyroid function tests and troponin), potentially leading to inaccurate results. The MHRA has issued guidance on this risk.
Stress management is also relevant, as chronic psychological or physiological stress is a well-recognised trigger for telogen effluvium. Techniques such as mindfulness, regular physical activity, and adequate sleep may help regulate the stress response and support overall wellbeing. Smoking cessation is also advisable, as smoking has been associated with androgenetic alopecia.
In terms of hair care practices, avoiding excessive heat styling, tight hairstyles (which can cause traction alopecia), and harsh chemical treatments may help reduce mechanical damage to existing hair. Using gentle hair care products and handling hair carefully is sensible, though no specific shampoo formulation has been shown to promote hair regrowth. Minimising further damage is a reasonable precaution whilst addressing any underlying cause.
When to See a GP About Hair Loss
See a GP promptly if hair loss is sudden, patchy, associated with scalp changes, or accompanied by systemic symptoms such as fatigue or weight changes, as these may indicate a treatable underlying condition.
Many people experience some degree of hair shedding throughout their lives, and not all hair loss requires medical attention. However, there are specific circumstances in which it is important to consult a GP promptly to rule out an underlying condition or access appropriate treatment.
You should see a GP if you notice:
-
Sudden or rapid hair loss over a short period
-
Patchy hair loss, particularly in circular or irregular patterns
-
Hair loss accompanied by scalp redness, scaling, itching, or pain — which may suggest a scarring alopecia or tinea capitis requiring urgent assessment
-
Loss of follicular openings on the scalp, which can be a sign of scarring alopecia; early referral to dermatology is important to prevent permanent loss
-
Thinning eyebrows, eyelashes, or body hair alongside scalp hair loss
-
Hair loss associated with other symptoms such as fatigue, weight changes, or irregular periods — which may suggest a hormonal or systemic cause
-
Significant psychological distress related to hair loss, including anxiety or low mood
-
Hair loss in a child, particularly with scalp scaling or broken hairs, which may indicate tinea capitis requiring systemic antifungal treatment
A GP will typically take a thorough medical and family history, examine the scalp, and arrange relevant blood tests where clinically indicated to identify or exclude treatable causes. If an underlying condition such as thyroid disease or iron deficiency is identified, treating that condition often leads to natural improvement in hair growth over time.
Referral to an NHS dermatologist may be arranged where the diagnosis is uncertain, hair loss is extensive, or initial treatments have not been effective. In some cases, referral to an endocrinologist or gynaecologist may be appropriate, particularly for women with signs of hormonal imbalance. Suspected scarring alopecia warrants urgent dermatology referral.
It is also advisable to seek GP advice before starting any new supplement or over-the-counter hair loss treatment, particularly if you are taking other medications or have existing health conditions. If you experience any suspected side effects from a hair loss treatment, report these via the MHRA Yellow Card Scheme at yellowcard.mhra.gov.uk or via the Yellow Card app. Early assessment and intervention generally lead to better outcomes, so there is no benefit in delaying a consultation if you have concerns.
For psychological support, NHS talking therapies (such as those available through IAPT services in England) can be accessed via GP referral or self-referral, and may be beneficial for those experiencing significant distress related to hair loss.
Frequently Asked Questions
What is the most effective treatment for hair loss in the UK?
The most effective treatment depends on the cause. Topical minoxidil is the most widely used over-the-counter option for pattern hair loss, whilst finasteride (prescription-only) is licensed for men. For severe alopecia areata, specialist-initiated JAK inhibitors such as baricitinib or ritlecitinib may be appropriate.
Can hair loss be treated on the NHS?
Androgenetic alopecia is generally considered cosmetic and is not routinely treated on the NHS. However, hair loss caused by an underlying medical condition — such as thyroid disease or iron deficiency — will be investigated and managed. Specialist treatments for alopecia areata, including JAK inhibitors, may be available via the NHS subject to NICE technology appraisal criteria.
When should I see a GP about hair loss?
You should see a GP if hair loss is sudden, patchy, or accompanied by scalp redness, scaling, or pain, as these may indicate scarring alopecia or tinea capitis requiring urgent assessment. A GP should also be consulted if hair loss is associated with fatigue, weight changes, or significant psychological distress.
The health-related content published on this site is based on credible scientific sources and is periodically reviewed to ensure accuracy and relevance. Although we aim to reflect the most current medical knowledge, the material is meant for general education and awareness only.
The information on this site is not a substitute for professional medical advice. For any health concerns, please speak with a qualified medical professional. By using this information, you acknowledge responsibility for any decisions made and understand we are not liable for any consequences that may result.
Any third-party brands or services referenced on this site are included for informational purposes only; we are entirely independent and have no affiliation, partnership, or collaboration with any companies mentioned.
Heading 1
Heading 2
Heading 3
Heading 4
Heading 5
Heading 6
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat. Duis aute irure dolor in reprehenderit in voluptate velit esse cillum dolore eu fugiat nulla pariatur.
Block quote
Ordered list
- Item 1
- Item 2
- Item 3
Unordered list
- Item A
- Item B
- Item C
Bold text
Emphasis
Superscript
Subscript
